Neurosense Therapeutics Ltd. (NRSN)
Market Open
11 Sep, 13:31
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
0. 34
+0.01
+2.3795%
$
18.06M Market Cap
- P/E Ratio
- Div Yield
20,636 Volume
-0.8 Eps
$ 0.33
Previous Close Want to track NRSN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurosense Therapeutics Ltd. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 22,775 | $16,400 | $7,820.93 | -$8,579.07 | -52.31% |
| RJ Rebecca Judd Pathstone Holdings, LLC | 16,528 | $12,710 | $7,746.67 | -$4,963.33 | -39.05% |
